Xovak Pharmtech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-12-2024
- Paid Up Capital ₹ 0.10 M
as on 25-12-2024
- Company Age 8 Year, 10 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 713.48%
(FY 2022)
- Profit 71.92%
(FY 2022)
- Ebitda 8.93%
(FY 2022)
- Net Worth -1.00%
(FY 2022)
- Total Assets 28.69%
(FY 2022)
About Xovak Pharmtech
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Dangar and Divyaraj Dangar serve as directors at the Company.
- CIN/LLPIN
U74110GJ2017PTC095011
- Company No.
095011
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Xovak Pharmtech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Dangar  | Director | 05-Jan-2017 | Current |
| Divyaraj Dangar | Additional Director | 09-Jun-2021 | Current |
Financial Performance of Xovak Pharmtech.
Xovak Pharmtech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 713.48% increase. The company also saw a substantial improvement in profitability, with a 71.92% increase in profit. The company's net worth dipped by a decrease of 1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xovak Pharmtech?
In 2018, Xovak Pharmtech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Xovak Pharmtech?
Unlock and access historical data on people associated with Xovak Pharmtech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xovak Pharmtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xovak Pharmtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
